Quick Read – BMY’s 17 consecutive dividend raises and VZ’s $20B in annual free cash flow make both the dependable income anchors of this trio. – Pfizer’s free cash flow covered only 93% of its 2025 dividends, its first shortfall since 2023, putting its 6.6% yield on close watch….
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Verizon didn’t make the cut. Grab the names FREE today
At 66 with $1.3 million, the math is straightforward. A 5% blended yield throws off roughly $65,000 a year before Social Security. The cash flow underneath these three blue chips is what matters most for a retiree.
I dug into each dividend to see which ones a 66-year-old can actually rely on. Bristol Myers Squibb: Patent Cliff Meets a 41% Payout Ratio Bristol Myers Squibb (NYSE:BMY) just raised its payout for a 17th consecutive year, backed by 94 straight years of dividend payments. The Growth Portfolio rose 12% to $6.23B in Q1 2026, with Eliquis up 16% and Camzyos up 97%.